Paid Clinical Trials in Pennsylvania

Pennsylvania has 3,659 paid clinical trials enrolling now across cities including Philadelphia, Pittsburgh and Hershey. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Pennsylvania include Penn Medicine, Children's Hospital of Philadelphia and UPMC, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 4, 2026.

Filter results

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

3,659 clinical trials

↓ Download CSV

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

for Chronic Obstructive Pulmonary Disease (COPD)

Drug: Omalizumab

23 locations incl. Birmingham

Sponsor: Johns Hopkins University

Sex: All·Age: 40+

Code: NCT07059091·Phase 2·Recruiting

Apply to this trial

Distance-Based Exercise to Preserve Function and Prevent Disability

for Hematopoietic and Lymphatic System Neoplasm

17 locations incl. Dublin

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT07059884·Recruiting

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

for Moderate to Severe Chronic Obstructive Pulmonary Disease

Drug: PF-07275315

30 locations incl. Dothan

Sponsor: Pfizer

Sex: All·Age: 35 - 80

Code: NCT07363694·Phase 2, Phase 3·Recruiting

Apply to this trial

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

for Familial Pulmonary Fibrosis

Drug: Nerandomilast

13 locations incl. Los Angeles

Sponsor: Boehringer Ingelheim

Sex: All·Age: 40+

Code: NCT07201922·Phase 3·Recruiting

Apply to this trial

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

for Sepsis

16 locations incl. Tucson

Sponsor: AstraZeneca

Sex: All·Age: 18 - 80

Code: NCT07215702·Phase 2·Recruiting

Apply to this trial

Eatwell Clinical Trial (R01)

for Cancer Prevention

1 location in Philadelphia

Sponsor: Drexel University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07225881·Recruiting

Apply to this trial

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

for Neoplasms, Prostate

3 locations incl. Grand Rapids

Sponsor: GlaxoSmithKline

Sex: Male·Age: 18+

Code: NCT07332455·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

for Sleep Apnea, Obstructive

Drug: Eloralintide

24 locations incl. Cullman

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07369011·Phase 3·Recruiting

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

for Overweight

Drug: Eloralintide

52 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07392190·Phase 3·Recruiting

Apply to this trial

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

for Age Related Cataracts

21 locations incl. Scottsdale

Sponsor: Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.

Sex: All·Age: 50+

Code: NCT07395986·Phase 2·Enrolling By Invitation

A Study of Brenipatide in Adult Participants With Schizophrenia

for Schizophrenia

Drug: Brenipatide

31 locations incl. Little Rock

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 55

Code: NCT07410507·Phase 2·Recruiting

Apply to this trial

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

for Osteoarthritis

Drug: Eloralintide

36 locations incl. Mobile

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07353931·Phase 3·Recruiting

Apply to this trial

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

for Uncontrolled Gout

36 locations incl. Tustin

Sponsor: Amgen

Sex: All·Age: 18+

Code: NCT07388498·Phase 3·Recruiting

Apply to this trial

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

for Depressive Disorder, Major

Drug: Brenipatide

32 locations incl. Moorpark

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 75

Code: NCT07412756·Phase 3·Recruiting

Apply to this trial

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

for Diabetic Macular Edema

Drug: Aflibercept

48 locations incl. Gilbert

Sponsor: EyePoint Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07449923·Phase 3·Recruiting

Apply to this trial

A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

for Traumatic Brain Injury

13 locations incl. Sacramento

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07455136·Recruiting

Apply to this trial

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

29 locations incl. Birmingham

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07266441·Phase 2·Recruiting

Apply to this trial

BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia

for Endotracheal Extubation

2 locations incl. Winston-Salem

Sponsor: Telethon Kids Institute

Sex: All·Age: 0 - 16

Code: NCT07204990·Recruiting

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

for Obesity

Drug: Eloralintide

41 locations incl. Tuscaloosa

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07321886·Phase 3·Recruiting

Apply to this trial

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

for Diabetes Mellitus, Type 1

Drug: Baricitinib

5 locations incl. Aurora

Sponsor: Eli Lilly and Company

Sex: All·Age: 1 - 35

Code: NCT07222332·Phase 3·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

for Dystonia

37 locations incl. Birmingham

Sponsor: Vima Therapeutics

Sex: All·Age: 18 - 65

Code: NCT07304089·Phase 2·Recruiting

Apply to this trial

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

16 locations incl. Los Angeles

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07258511·Phase 3·Recruiting

Apply to this trial

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

for Prosthetic-joint Infection

9 locations incl. Sarasota

Sponsor: Peptilogics

Sex: All·Age: 18 - 80

Code: NCT07214311·Phase 2, Phase 3·Recruiting

Apply to this trial

Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions: Aim 2

for Attention Deficit Hyperactivity Disorder Symptoms

1 location in Philadelphia

Sponsor: Children's Hospital of Philadelphia

Sex: All·Age: 4+·Accepts healthy volunteers

Code: NCT07321327·Enrolling By Invitation

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for Gastric Cancer

Drug: Sonesitatug vedotin

77 locations incl. Phoenix

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07431281·Phase 3·Recruiting

Apply to this trial

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

for Hidradenitis Suppurativa (HS)

Drug: Povorcitinib

25 locations incl. Birmingham

Sponsor: Incyte Corporation

Sex: All·Age: 12 - 17

Code: NCT07213973·Phase 2·Recruiting

Apply to this trial

Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application

for Cancer

1 location in Pittsburgh

Sponsor: University of Pittsburgh

Sex: All·Age: 18+

Code: NCT07218874·Recruiting

Apply to this trial

Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design

for Autism Spectrum Disorder

1 location in Middletown

Sponsor: Penn State University

Sex: All·Age: 18 - 45

Code: NCT07432776·EARLY_Phase 1·Recruiting

Apply to this trial

Light Therapy in End Stage Kidney Disease

for End Stage Renal Disease

1 location in Philadelphia

Sponsor: University of Pennsylvania

Sex: All·Age: 18+

Code: NCT06310161·Recruiting

Apply to this trial

Study to Enable New Diagnostics for Pulmonary Microbes in People With CF

for Cystic Fibrosis (CF)

9 locations incl. La Jolla

Sponsor: Chris Goss

Sex: All·Age: 16+

Code: NCT07312734·Not Yet Recruiting

Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness

for Gestational Diabetes

3 locations incl. Santa Barbara

Sponsor: Oregon Health and Science University

Sex: Female·Age: 18+

Code: NCT07356986·Not Yet Recruiting

Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

for Autosomal Dominant Hypocalcemia Type 1 (ADH1)

4 locations incl. New Haven

Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company

Sex: All·Age: 0 - 17

Code: NCT07080385·Phase 2, Phase 3·Recruiting

Apply to this trial

Increasing Germline Genetic Testing for Patients With Cancer

for Hereditary Pancreatic Cancer

10 locations incl. Los Angeles

Sponsor: Josh Peterson

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT07307664·Recruiting

Apply to this trial

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

for Painful Peripheral Neuropathy

7 locations incl. Boston

Sponsor: University of Rochester

Sex: All·Age: 18 - 80

Code: NCT06614322·Phase 2·Recruiting

Apply to this trial

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

for Hepatitis

Drug: Larsucosterol

48 locations incl. Birmingham

Sponsor: Bausch Health Americas, Inc.

Sex: All·Age: 18+

Code: NCT07428538·Phase 3·Recruiting

Apply to this trial

A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients

for Acute Kidney Injury

1 location in Philadelphia

Sponsor: University of Pennsylvania

Sex: All·Age: 18+

Code: NCT06954129·Phase 4·Recruiting

Apply to this trial

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

for Glioblastoma

8 locations incl. Boston

Sponsor: Alpheus Medical, Inc.

Sex: All·Age: 18 - 80

Code: NCT07225621·Phase 2·Recruiting

Apply to this trial

Brain-Stomach Circuits in Chronic Nausea

for Chronic Nausea and Vomiting Syndrome

1 location in Pittsburgh

Sponsor: David Levinthal

Sex: All·Age: 21 - 60·Accepts healthy volunteers

Code: NCT07276035·Recruiting

Apply to this trial

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

for Eosinophilic Asthma

20 locations incl. Long Beach

Sponsor: Kymera Therapeutics, Inc.

Sex: All·Age: 18 - 75

Code: NCT07323654·Phase 2·Recruiting

Apply to this trial

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

for Stargardt Disease

3 locations incl. Bakersfield

Sponsor: Ray Therapeutics, Inc.

Sex: All·Age: 16+

Code: NCT07439887·Phase 1, Phase 2·Recruiting

Apply to this trial